Bluejay Diagnostics authorizes Nov 2026 reverse stock split
Bluejay Diagnostics increased authorized shares and approved a reverse stock split effective Nov 3, 2026. This corporate action aims to improve share price liquidity and market perception.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed